Syndex Bio
Syndex Bio is a biotechnology platform offering molecular technologies and AI for the diagnosis and treatment of disease.
$15.5M Seed ·
Source: European Biotechnology Magazine
Funding history ↓Signals
Website registeredJan 14, 2022 (4 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $15.5M | — | European Biotechnology Magazine |
Timeline
- Website created
Founders and team
GS
Geoff Smith Founder
Companies like Syndex Bio
IIsaac Health$10.5M Series A · Aug 2025
IInocras$31M Series B+ · Aug 2026
PPengrui Brain SciencePre Seed · Oct 2026
MMULTI4 MEDICALSeed · Apr 2026
AAtavistik Bio$40M Series B+ · Mar 2026
OOligomerix$2.7M Series B+ · Jun 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/syndex-bio (get a free API key).